National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Sofosbuvir/Velpatasvir (Epclusa®) for the treatment of chronic hepatitis C virus (HCV) infection in adults

Rapid Review

Commenced Completed Outcome
12/07/2016 23/08/2016 Full pharmacoeconomic evaluation not recommended for HCV genotype 3 infection